Literature DB >> 20113912

Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits.

Myung H Park, Gautam V Ramani, Willem J Kop, Patricia A Uber, Mandeep R Mehra.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20113912     DOI： 10.1016/j.healun.2009.10.010

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

1.  Open label study of ambrisentan in patients with exercise pulmonary hypertension.

Authors:  Sergio A Segrera; Laurie Lawler; Alexander R Opotowsky; David Systrom; Aaron B Waxman
Journal:  Pulm Circ       Date:  2017-05-12       Impact factor: 3.017

2.  Intravenous sildenafil acutely improves hemodynamic response to exercise in patients with connective tissue disease.

Authors:  Andreas J Rieth; Manuel J Richter; Alexander Berkowitsch; Marc Frerix; Ingo H Tarner; Veselin Mitrovic; Christian W Hamm
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

3.  Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility.

Authors:  William D Wallace; Mehdi Nouraie; Stephen Y Chan; Michael G Risbano
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.